| scholarly article | Q13442814 |
| P2093 | author name string | H. Stähelin | |
| J. F. Borel | |||
| C. Feurer | |||
| C. Magnée | |||
| P2860 | cites work | Biological effects of cyclosporin A: A new antilymphocytic agent | Q28299720 |
| Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity | Q34460513 | ||
| Crystal and molecular structure of an iodo-derivative of the cyclic undecapeptide cyclosporin A. | Q43455824 | ||
| Hypersensitivity in mice. I. Induction of contact sensitivity to oxazolone and inhibition by various chemical compounds | Q43482689 | ||
| Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity | Q44162251 | ||
| Evidence for thymus-independent humoral antibody production in mice against polyvinylpyrrolidone and E. coli lipopolysaccharide | Q47739744 | ||
| Comparison of the immune response to sheep erythrocytes, tetanus toxoid and endotoxin in different strains of mice | Q53773799 | ||
| [Pharmacological susceptibility of cellular immunity] | Q72716770 | ||
| The use of spiral loops in serological and virological micro-methods | Q73952116 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cyclosporine | Q367700 |
| lymphocyte | Q715347 | ||
| P304 | page(s) | 1017-1025 | |
| P577 | publication date | 1977-06-01 | |
| P1433 | published in | Immunology | Q15754984 |
| P1476 | title | Effects of the new anti-lymphocytic peptide cyclosporin A in animals | |
| P478 | volume | 32 |
| Q42408980 | 99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A. |
| Q42608542 | A placebo-controlled blind trial of cyclosporin-A in prevention of corneal graft rejection in rabbits |
| Q37175992 | A review of the current status and techniques of allogeneic bone marrow transplantation for treatment of leukaemia |
| Q70355565 | Action of cyclosporine on mitochondrial calcium fluxes |
| Q46684361 | Actions of aspirin and dipyridamole on lymphocyte activation |
| Q35208343 | Activation of antigen-specific suppressor T cells in the presence of cyclosporin requires interactions between T cells of inducer and suppressor lineage |
| Q42767886 | Additive and synergistic antiproliferative effects of cyclosporin A and gamma interferon on cultured human keratinocytes. |
| Q40184313 | Antibody response after influenza immunization in renal transplant patients receiving cyclosporin A or azathioprine |
| Q47992817 | Antimalarial activity of cyclosporin A. |
| Q37027552 | Antischistosomal effect of cyclosporin A: cure and prevention of mouse and rat schistosomiasis mansoni |
| Q48656763 | Blood and tissue distribution of cyclosporin A after a single oral dose in the rat. |
| Q37296331 | Calcineurin inhibition enhances motor neuron survival following injury |
| Q42203221 | Changes in the tumorigenic and metastatic properties of murine melanoma cells treated with a triazene derivative |
| Q41038067 | Clinical use of cyclosporin in rheumatoid arthritis |
| Q64994145 | Comparative Genomics and Transcriptomics During Sexual Development Gives Insight Into the Life History of the Cosmopolitan Fungus Fusarium neocosmosporiellum. |
| Q72790043 | Comparative study of cyclomunine and cyclosporin A on human lymphocyte proliferation in vitro the lack of an immunosuppressive effect by specific clonal deletion |
| Q70999434 | Comparison of the inhibition by glucocorticosteroids and cyclosporin A of mitogen-stimulated human lymphocyte proliferation |
| Q46327674 | Comparison of the pharmacological profiles of cyclosporine, (Nva2)-cyclosporine and (Val2)dihydro-cyclosporine. |
| Q34207236 | Current Status of Hepatic Transplantation |
| Q37577487 | Cyclophilin A: a key player for human disease |
| Q37660604 | Cyclophilin D in mitochondrial pathophysiology |
| Q28507223 | Cyclophilin D modulates mitochondrial F0F1-ATP synthase by interacting with the lateral stalk of the complex |
| Q33556926 | Cyclosporin A (CyA) in primary Sjögren's syndrome: a double blind study |
| Q37164604 | Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients |
| Q70195676 | Cyclosporin A applied topically to the recipient eye inhibits corneal graft rejection |
| Q33935614 | Cyclosporin A enhances neural precursor cell survival in mice through a calcineurin-independent pathway |
| Q68976408 | Cyclosporin A has differential effects on the responses of murine B cells to TI antigens and B-cell mitogens |
| Q36660164 | Cyclosporin A in clinical organ grafting. First Northern Ireland Kidney Research Fund lecture. |
| Q50563197 | Cyclosporin A in paediatric kidney transplantation. |
| Q35755731 | Cyclosporin A inhibits Coccidioides immitis in vitro and in vivo |
| Q37564002 | Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription |
| Q70268400 | Cyclosporin A inhibits acute serum sickness nephritis in rabbits |
| Q38536786 | Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines. |
| Q69135098 | Cyclosporin A inhibits mitogen-activated but not phorbol ester-activated locomotion of human lymphocytes |
| Q36992132 | Cyclosporin A inhibits the growth of Cryptococcus neoformans in a murine model |
| Q68991103 | Cyclosporin A prevents suppression of delayed-type hypersensitivity in mice immunized with high-dose sheep erythrocytes |
| Q24645745 | Cyclosporin A prevents the anti-murine antibody response to a monoclonal anti-tumour antibody in rabbits |
| Q69377699 | Cyclosporin A prevents the in vivo development of murine prothymocytes from uncommitted (Thy-1-) precursor cells |
| Q35202443 | Cyclosporin A-treated guinea pig responder cells secrete a genetically restricted factor that suppresses the mixed leukocyte reaction |
| Q40246910 | Cyclosporin A. Clinical pharmacology and therapeutic potential |
| Q64925890 | Cyclosporin A: Effects on the mouse thymus |
| Q40615260 | Cyclosporin A: a new advance in transplantation. |
| Q34278064 | Cyclosporin A: a powerful immunosuppressant |
| Q70436213 | Cyclosporin A: correlation between HPLC and RIA serum levels |
| Q40709188 | Cyclosporin A: in vivo and in vitro suppression of rat T-lymphocyte function |
| Q70302607 | Cyclosporin a used alone or in combination with low-dose steroids in cadaveric renal transplantation |
| Q70302612 | Cyclosporin a: Pharmacologic activity on the immune system and effects in clinical organ transplantation |
| Q72084686 | Cyclosporin receptor on mouse lymphocytes |
| Q37247310 | Cyclosporin-A associated malignancy. |
| Q72114406 | Cyclosporin-A inhibits accumulation of lymphocytes within lymph nodes |
| Q40490594 | Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders |
| Q68793184 | Cyclosporine affects the function of antigen-presenting cells |
| Q69914465 | Cyclosporine and partial liver allotransplants in a simplified rat model |
| Q54415537 | Cyclosporine inhibition of a murine B cell lymphoma. |
| Q36353085 | Cyclosporine-induced autoimmunity. Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats |
| Q40200051 | Cyclosporine: immunology, toxicity and pharmacology in experimental animals |
| Q45017047 | Cyclosporins: Immunosuppressive agents with antitumor activity |
| Q36355418 | Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity |
| Q68989020 | Development of high blood pressure in spontaneously hypertensive rats is delayed by treatment with cyclosporin at an early age |
| Q41217045 | Different effect of cyclosporin A on arthritides induced by a muramyl dipeptide analogue or the complete adjuvant in rats |
| Q40922766 | Differential effect of cyclosporin A on activation signaling in human T cell lines |
| Q37246076 | Dose adjustment strategy of cyclosporine A in renal transplant patients: evaluation of anthropometric parameters for dose adjustment and C0 vs. C2 monitoring in Japan, 2001-2010. |
| Q42096302 | Effect of Cyclosporin A on rat thymus: time course analysis by immunoperoxidase technique and flow cytofluorometry |
| Q68194522 | Effect of cyclosporin A on autoimmune tubulointerstitial nephritis in the brown Norway rat |
| Q37053644 | Effect of cyclosporin A on immunity to Listeria monocytogenes |
| Q33912886 | Effect of cyclosporin A on murine natural killer cells |
| Q70021784 | Effect of cyclosporin A on the T-effector and T-suppressor cell response in contact sensitivity |
| Q42606397 | Effect of cyclosporin A on the survival of corneal grafts in rabbits |
| Q35582940 | Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients |
| Q37105986 | Effect of cyclosporine on the response of normal human lymphocytes to cytomegalovirus in vitro |
| Q35992617 | Effect of host immune status on the spontaneous metastasis of cloned cell lines of the 13762NF rat mammary adenocarcinoma |
| Q40136315 | Effect of immunosuppression on experimental Argentine hemorrhagic fever in guinea pigs |
| Q54332021 | Effects of a novel immunosuppressive agent, FK506, on human B cell activation |
| Q69495972 | Effects of cyclosporin A on active Crohn's disease |
| Q70376929 | Effects of cyclosporin A on expression of IL-2 and IL-2 receptors in normal and multiple sclerosis patients |
| Q41819761 | Effects of cyclosporin A on growth and polyamine metabolism of MOLT-4 T-lymphoblastic leukaemia cells |
| Q36860138 | Effects of cyclosporin A on humoral immune response and resistance against vesicular stomatitis virus in mice. |
| Q69709368 | Effects of cyclosporin A on humoral immunity to ticks and on cutaneous immediate and delayed hypersensitivity reactions to Ixodes ricinus L. salivary-gland antigens in re-infested rabbits |
| Q54497847 | Effects of cyclosporin A on the metabolism of unstimulated and mitogen-activated lymphocytes. |
| Q40163581 | Effects of immunosuppression on avian coccidiosis: cyclosporin A but not hormonal bursectomy abrogates host protective immunity |
| Q44862290 | Effects of topical cyclosporin A on guinea-pig toxic contact dermatitis |
| Q64078357 | Enhanced immunosuppressive effects of 3,5-bis[4(diethoxymethyl)benzylidene]-1-methyl-piperidin-4-one, an α, β-unsaturated carbonyl-based compound as PLGA--PEG nanoparticles |
| Q41874828 | Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites |
| Q37004603 | Evidence for a functional receptor for cyclosporin A on the surface of lymphocytes |
| Q54365775 | Evidence of a role for NK cells in oxazaphosphorine-mediated tumor regression. |
| Q34275840 | Evolution of liver transplantation |
| Q70386814 | Experience with cyclosporine and steroids in clinical renal transplantation |
| Q91905530 | Eye drop emulsion containing 0.1% cyclosporin (1 mg/mL) for the treatment of severe vernal keratoconjunctivitis: an evidence-based review and place in therapy |
| Q46157989 | Fatty acid metabolism and cell proliferation: IV. Effect of prostanoid biosynthesis from endogenous fatty acid release with cyclosporin-A. |
| Q34965480 | Fifteen years of clinical liver transplantation |
| Q39451470 | Generic immunosuppressants |
| Q42084523 | Hepatic and renal function in rats receiving immunotherapeutic doses of cyclosporin A |
| Q45309450 | Herpes simplex virus infection and damage in the central nervous system: immunomodulation with adjuvant, cyclophosphamide and cyclosporin A. |
| Q24596303 | History of clinical transplantation |
| Q52216958 | IgM memory: long lived hapten-specific memory in the newt, Notophthalmus viridescens. |
| Q36467488 | Immunosuppression by immunoglobulin deaggregation is not effective in reducing the anti-xenogeneic immunoglobulin response: experimental and clinical studies |
| Q37021214 | Immunosuppressive effect of cyclosporin A on Mycobacterium bovis BCG infections in mice |
| Q55120554 | In Vivo Comparative Evaluation of the Pomegranate (Punica granatum) Peel Extract as an Alternative Agent to Nystatin against Oral Candidiasis. |
| Q60609107 | In vitro and in vivo action of cyclosporin A on the induction of human interleukin-2 receptor alpha and beta chains |
| Q34529385 | In vitro effect of cyclosporin A on immunoglobulin production and concanavalin A induced suppression in primary biliary cirrhosis |
| Q68091298 | Influence of host defenses on the hepatic colonization of B16F10 melanoma cells |
| Q74059983 | Influences of immunosuppressive agents, FK506 and cyclosporin on systemic Candida albicans infection in mice |
| Q36333498 | Inhibition by cyclosporin A of rodent malaria in vivo and human malaria in vitro |
| Q46742214 | Inhibition of contact sensitivity reactions to DNFB by topical cyclosporin application in the guinea-pig |
| Q69888693 | Inhibition of growth and metastasis of syngeneic transplantable tumours by an aromatic retinoic acid analogue. 2. T cell dependence of retinoid effects in vivo |
| Q44793592 | Inhibition of herpes simplex virus production in vitro by Cyclosporin A |
| Q67258862 | Inhibition of mitogen-induced lymphokine production by cyclosporin A |
| Q70565946 | Inhibition of mouse natural killer activity by cyclosporin A |
| Q72100019 | Inhibitory effect of cyclosporin A on peripheral blood and bone marrow T lymphocyte colony formation |
| Q41560578 | Interactions between cyclosporin A, indomethacin and 16,16-dimethyl prostaglandin E2: effects on renal, hepatic and gastrointestinal toxicity in the rat. |
| Q38535503 | Interleukin-2 effect on the inhibition of mixed lymphocyte reaction induced by cyclosporin A. |
| Q35028364 | Intestinal graft-versus-host disease: mechanisms and management |
| Q34240601 | Isohemagglutinins of graft origin after ABO-unmatched liver transplantation |
| Q34397330 | Lack of effect of spiramycin on cyclosporin pharmacokinetics |
| Q34561587 | Liver and kidney transplantation in children receiving cyclosporin A and steroids |
| Q33752966 | Liver transplantation, 1980, with particular reference to cyclosporin-A. |
| Q33616157 | Liver transplantation--the first 25 years |
| Q93504676 | Lung transplantation |
| Q38778422 | Management of High-risk Corneal Transplantation |
| Q70306997 | Marked reduction of DNA antibody production and glomerulopathy in thymulin (FTS-Zn) or cyclosporin A treated (NZB X NZW) F1 mice |
| Q41144114 | Mechanism of action of cyclosporin in rheumatoid arthritis |
| Q42594006 | Modification of c and n sources for enhanced production of cyclosporin 'a' by Aspergillus Terreus |
| Q38536778 | Modification of delayed-type hypersensitivity reactions to ovalbumin in cyclosporin A-treated guinea-pigs. |
| Q91981315 | Oceans as a Source of Immunotherapy |
| Q40154877 | Opsonic activity of cerebrospinal fluid in experimental cryptococcal meningitis. |
| Q41822532 | Orthotopic liver transplantation in children: two-year experience with 47 patients. |
| Q30429819 | Oxazolone-induced delayed type hypersensitivity reaction in the adult yucatan pigs. A useful model for drug development and validation |
| Q36348238 | Paradoxical effects of cyclosporin A on collagen arthritis in rats |
| Q34275886 | Past and future prospects of orthoptic liver transplantation |
| Q35572368 | Pharmacodynamic monitoring of cyclosporin |
| Q36935033 | Pharmacokinetic Interactions with Calcium Channel Antagonists (Part II) |
| Q36353053 | Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis |
| Q83084099 | Poster communications |
| Q35858507 | Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A |
| Q47914796 | Prevention of murine cerebral malaria by low-dose cyclosporin A. |
| Q67232430 | Proceedings of the Annual Meeting of the European Foundation for Bone Marrow Transplantation, Sils Maria (Engadine), Switzerland, April 13-16, 1980 |
| Q39955829 | Production of Cyclosporine A by Submerged Fermentation from a Local Isolate of Penicillium fellutanum |
| Q43807128 | Prolongation of life in female NZB/NZW (F1) hybrid mice by cyclosporin A. |
| Q34275901 | Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors |
| Q36148596 | Recent advances in the treatment of graft-versus-host disease |
| Q36845991 | Recombinant Pseudorabies Virus (PRV) Expressing Firefly Luciferase Effectively Screened for CRISPR/Cas9 Single Guide RNAs and Antiviral Compounds |
| Q39603950 | Regulation of lymphocyte growth by antagonists of interleukin-2 or its cellular receptor |
| Q36466737 | Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin A. |
| Q70855628 | Selective effects of immunosuppressive agents against the delayed hypersensitivity response and humoral response to sheep red blood cells in mice |
| Q40615033 | Selective induction of immunological tolerance in antiviral T killer cells of inbred mice after treatment with cyclosporin A. |
| Q36348079 | Selective suppression of an early step in human B cell activation by cyclosporin A |
| Q36090368 | Severe systemic vascular necrosis in cyclosporin-treated rabbits with acute serum sickness |
| Q39603959 | Soluble inhibitors of T lymphocyte proliferation: tools for dissecting pathways of T cell activation |
| Q36351226 | Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells |
| Q35298344 | Stage-selective inhibition of rodent malaria by cyclosporine |
| Q34497811 | Steps in immunosuppression for renal transplantation |
| Q40714418 | Studies on the mechanism of action of cyclosporin A [proceedings] |
| Q68803408 | Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies |
| Q43543190 | Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: II. Reduction of glomerulonephritis |
| Q41066788 | Supporting future surgical innovation. Lung transplantation as a case study |
| Q38536674 | Suppression of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse. |
| Q53929186 | Suppression of experimental allergic neuritis by Cyclosporin-A. |
| Q46625153 | Synergism between aspirin and cyclosporin-A. |
| Q38904800 | Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation |
| Q36146320 | The Mitochondrial Permeability Transition Pore: Channel Formation by F-ATP Synthase, Integration in Signal Transduction, and Role in Pathophysiology. |
| Q42545449 | The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1-/- myopathic mice. |
| Q71640769 | The cyclosporins |
| Q34350677 | The design and development of an immunosuppressive drug, mycophenolate mofetil |
| Q72753732 | The effect of cyclosporin A on peripheral blood T cell subpopulations in renal allografts |
| Q45839043 | The effects of cyclosporin A on the induction, expression and regulation of the immune response to herpes simplex virus. |
| Q28274108 | The history of cyclosporin A (Sandimmune) revisited: another point of view |
| Q39486290 | The influence of cyclosporin A on cell-mediated immunity |
| Q70058692 | The influence of cyclosporin A on the induction of experimental autoimmune thyroid disease in the PVG/c rat |
| Q28279895 | The mitochondrial permeability transition from yeast to mammals |
| Q38106976 | The mitochondrial permeability transition pore: a mystery solved? |
| Q28248925 | The mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotection |
| Q46783142 | The modulation of intra-articular inflammation, cartilage matrix and bone loss in mono-articular arthritis induced by heat-killed Mycobacterium tuberculosis |
| Q40709485 | The oligomycin-sensitivity conferring protein of mitochondrial ATP synthase: emerging new roles in mitochondrial pathophysiology |
| Q37305573 | The use of cyclosporin A and prednisone in cadaver kidney transplantation |
| Q35856501 | Thymic and lymphoid changes and serum immunoglobulin abnormalities in mice receiving cyclosporine |
| Q68949586 | Topical cyclosporin A in nickel contact hypersensitivity: results of a preliminary clinical and immunohistochemical investigation |
| Q40155197 | Toxicological evaluation of cyclosporin A. |
| Q33916202 | Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in hemiparkinsonian rodents |
| Q35811806 | Vascular effects of cyclosporine A in vivo and in vitro |
| Q73900015 | [Perioperative implications of heart transplant] |
Search more.